ArticleHemaSphere2023

High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL.

Paul J Hengeveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.